Renowned physician Dr. Vladimir Zelenko downplayed the significance of the newly discovered IHU variant of the Wuhan coronavirus (COVID-19) during the Jan. 5 episode of “The Dr. Ardis Show” with Dr. Bryan Ardis on Brighteon.TV.
“There is nothing to worry about,” Zelenko said, referring to the variant first found in France. “I have no concern because I understand the biology behind these viruses, and I understand the treatment approaches and the mechanisms of action.”
Zelenko encouraged people to get treated early and avoid having the infection get out of control. “If someone has cancer, we don’t wait for it to be metastatic, all over the place, before we treat it. We prefer to treat it while it’s small and localized, you get much better results,” he said.
Experts were also quick to announce that the presence of a new variant does not necessarily mean that it could be as infectious as other strains. The IHU variant is known to have infected 12 people living in the southeastern part of France, with the first case linked to a person who recently traveled to Cameroon, Western Africa.
Researchers already found 46 mutations of the disease, which has not been spotted in other countries nor labeled a variant by the World Health Organization (WHO).
Eric Feigl-Ding, an epidemiologist and fellow at the Federation of American Scientists, wrote in a Twitter thread that the new variant is now being monitored and evaluated to better understand how infectious or dangerous it could be. There are many variants discovered all the time, but they don’t necessarily mean they will be dangerous.
Feigl-Ding noted that a variant’s ability to multiply because of the number of mutations it has in relation to the original virus makes it a “variant of concern,” similar to omicron. However, it still remains to be seen in which category the new IHU variant will fall.
During his appearance on “The Dr. Ardis Show,” Zelenko said that treating COVID patients early could prevent complications like lung damage and blood clots. He added that high-risk patients should be treated aggressively with combination of affordable, safe and very effective antivirals and anti-inflammatory drugs. (Related: COVID-19 vaccines are genocide, legendary doctor says.)
He noted that the different COVID variants have mutations on their spike proteins, and this information is clinically important. This is because they get into the cells in a unique and novel way, and existing defenses of previous antibodies are ineffective when it comes to recognizing the new threat.
Zelenko said that while he doesn’t care how the virus gets into the cell, it is important that the virus does not hijack the cells and their metabolic machinery, then make copies of its genetic material.
“If the virus cannot make copies of its genetic material, it can’t spread. And if you can’t spread, your immune system takes care of it,” he explained. “By blocking the enzyme RNA, dependent RNA polymerase with zinc, it’s the bullet to shut down the factory that the virus needs to make copies of its genetic material.”
The physician explained in detail what he prescribes his patients. He said anti-inflammatory drugs became crucial because the inflammatory component of the disease is what kills everyone. Blood thinners are also important because the disease causes blood clots. Zelenko encouraged the use of ivermectin, a miracle drug used all over the world, because it has both antiviral and anti-inflammatory properties. (Related: Minnesota medical board harasses doctor for prescribing ivermectin.)
He also emphasized tweaking protocols based on the needs of the patients, as it is not the same for every person, and each one should be evaluated.
Watch the full January 5 episode of “The Dr. Ardis Show” below.
You can catch “The Dr. Ardis Show” on Wednesdays at 10-11 a.m. on Brighteon.TV.
Follow Pandemic.news for more updates on the COVID-19 virus.
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.